JP
Revvity Sites Globally
Select your location.
*e-commerce not available for this region.
Application Note
AlphaLISA SureFire Ultra: elucidating TREM2/DAP12 signaling in neuroinflammation
Accelerate your research on neuroinflammatory pathways with the advanced AlphaLISA SureFire® Ultra™ platform. This innovative, no-wash assay technology offers exceptional sensitivity for studying key signaling events, including TREM2/DAP12 activation and its role in Alzheimer’s Disease (AD) pathology.
Key Highlights:
- Analyze critical TREM2/DAP12 signaling components, including phospho and aggregate states.
- Achieve rapid, reproducible results for post-translational modifications.
- Ideal for both immortalized cell lines and primary macrophages.
Discover how AlphaLISA SureFire® Ultra™ empowers breakthroughs in neurodegenerative disease research. Download the application note today.
For research use only. Not for use in diagnostic procedures.
To view the full content please answer a few questions
Download Resource
AlphaLISA SureFire Ultra: elucidating TREM2/DAP12 signaling in neuroinflammation